Dr. Chee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2008 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
- Royal Free Hospital and University College London Medical SchoolClass of 2004
Certifications & Licensure
- OH State Medical License 2011 - 2015
- MN State Medical License 2007 - 2012
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore.Cheng Ean Chee, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan
Expert Review of Pharmacoeconomics & Outcomes Research. 2024-06-01 - 3 citationsState-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.Priyadarshini S Pathak, Gloria Chan, Dustin A Deming, Cheng Ean Chee
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - 1 citationsEarly onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.Shehara Mendis, Lara Lipton, Yat Hang To, Sumitra Ananda, Michael Michael
British Journal of Cancer. 2024-05-01
Press Mentions
- State-of-the-Art Management of Colorectal Cancer: Treatment Advances and InnovationMay 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: